Suchergebnisse - "Xu, Binghe"

PubPharm (32)

1

Spotlight on ideal target antigens and resistance in antibody-drug conjugates : Strategies for competitive advancement

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Jiang, M. | Li, Q. | Xu, B.

2

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 status

enthalten in: International journal of cancer | 2023

von Jiang, M. | Liu, J. | Li, Q. | +1

3

The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges

enthalten in: The Lancet regional health. Western Pacific | 2023

von Huang, H. | Tang, Y. | Yu, Y. | +31

4

Advances in medical treatment of breast cancer in 2022

enthalten in: Cancer innovation | 2023

von Zhai, J. | Wu, Y. | Ma, F. | +2

5

Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses : A Systematic Review and Network Meta-Analysis

enthalten in: Cancers | 2022

von Wang, J. | Han, Y. | Wang, J. | +2

6

Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer : A Bayesian Network Meta-Analysis

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Han, Y. | Wang, J. | Wu, Y. | +3

7

Accelerating the integration of China into the global development of innovative anticancer drugs

enthalten in: The Lancet. Oncology | 2022

von Huang, H. | Wu, D. | Miao, H. | +12

8

GLORIA : phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancer

enthalten in: Future oncology (London, England) | 2022

von Rugo, H. | Cortes, J. | Barrios, C. | +9

9

Breast cancer : an up-to-date review and future perspectives

enthalten in: Cancer communications (London, England) | 2022

von Hong, R. | Xu, B.

10

Retrospective literature review of primary neuroendocrine neoplasms of the breast (BNEN) in 209 Chinese patients : Treatment and prognostic factor analysis

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Chai, Y. | Liu, M. | Li, Z. | +4